Skip to main content
SpringerLink
Log in

Urtikaria

Neue Medikamente gegen chronisch spontane Urtikaria

  • Fortbildung
  • Published:
hautnah dermatologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Kavati A et al. Long-term omalizumab outcomes in chronic idiopathic urticaria: A real-world study. Allergy Asthma Proc 2019; 40: 321-8

    Article  Google Scholar 

  2. Lapeere H et al. A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: A real-world study in Belgium. J Eur Acad Dermatol Venereol. 2019; http://doi.org/10.1111/jdv.15684

    Article  Google Scholar 

  3. Maurer M et al. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study. Clin Exp Allergy 2019; 49: 655-62

    Article  Google Scholar 

  4. Magen E et al. Factors related to omalizumab resistance in chronic spontaneous urticaria. Allergy Asthma Proc 2019; 40: 273-8

    Article  CAS  Google Scholar 

  5. Marzano AV et al. Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients. J Eur Acad Dermatology Venereol 2019; 33: 918-4

    Article  Google Scholar 

  6. Maurer M et al. Ligelizumab for Chronic Spontaneous Urticaria. N Engl J Med 2019; 381: 1321-32

  7. Kulthanan K et al. Factors Predicting the Response to Cyclosporin Treatment in Patients With Chronic Spontaneous Urticaria: A Systematic Review. Allergy Asthma Immunol Res 2019; 11: 736-55

    Article  Google Scholar 

  8. Pathania YS et al. Comparing azathioprine with cyclosporine in the treatment of antihistamine refractory chronic spontaneous urticaria: A randomized prospective active-controlled non-inferiority study. World Allergy Organ J 2019; 12: 100033

    Article  Google Scholar 

  9. Yu L et al. Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria. J Eur Acad Dermatol Venereol 2019; 33: 1747-54

    Article  CAS  Google Scholar 

  10. Liang SE et al. Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria. JAMA Dermatology 2019; 155: 90

    Article  Google Scholar 

  11. Kocatürk E et al. New biologics in the treatment of urticaria. Curr Opin Allergy Clin Immunol 2018; 18: 425-31

    Article  Google Scholar 

  12. Lee JK et al. Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria. J Allergy Clin Immunol Pract 2019; 7: 1659-61

    Google Scholar 

  13. Magerl M et al. Benefit of mepolizumab treatment in a patient with chronic spontaneous urticaria. J Dtsch Dermatol Ges 2018; 16: 477-8

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wilhelm-Univ. Münster, Abtlg. Dermatologie, Von-Esmarch-Str. 58, 48149, Münster, Germany

    Randolf Brehler

Authors
  1. Randolf Brehler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Randolf Brehler.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brehler, R. Neue Medikamente gegen chronisch spontane Urtikaria. hautnah dermatologie 36 (Suppl 1), 12–18 (2020). https://doi.org/10.1007/s15012-019-0004-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15012-019-0004-9

Search

Navigation